FinTrust Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.7M Buy
1,918
+9
+0.5% +$8.09K 0.29% 82
2024
Q2
$1.73M Sell
1,909
-98
-5% -$78.4K 0.31% 65
2024
Q1
$1.56M Buy
2,007
+321
+19% +$228K 0.3% 69
2023
Q4
$983K Sell
1,686
-35
-2% -$20.4K 0.2% 104
2023
Q3
$925K Sell
1,721
-80
-4% -$41.2K 0.21% 106
2023
Q2
$659K Hold
1,801
0.16% 143
2023
Q1
$659K Hold
1,801
0.16% 140
2022
Q4
$659K Sell
1,801
-63
-3% -$22.3K 0.16% 139
2022
Q3
$625K Sell
1,864
-18
-1% -$5.7K 0.16% 138
2022
Q2
$619K Buy
1,882
+66
+4% +$19.8K 0.15% 140
2022
Q1
$519K Buy
1,816
+137
+8% +$35.3K 0.12% 160
2021
Q4
$464K Hold
1,679
0.11% 171
2021
Q3
$388K Buy
1,679
+67
+4% +$16.5K 0.1% 182
2021
Q2
$370K Hold
1,612
0.1% 183
2021
Q1
$301K Hold
1,612
0.09% 202
2020
Q4
$272K Sell
1,612
-343
-18% -$51.2K 0.09% 196
2020
Q3
$289 Hold
1,955
0.06% 172
2020
Q2
$321K Buy
1,955
+155
+9% +$23.8K 0.13% 147
2020
Q1
$250K Hold
1,800
0.12% 153
2019
Q4
$237K Hold
1,800
0.1% 182
2019
Q3
$201K Hold
1,800
0.07% 211
2019
Q2
$199K Sell
1,800
-167
-8% -$19.7K 0.08% 188
2019
Q1
$256K Sell
1,967
-503
-20% -$61.2K 0.11% 161
2018
Q4
$286K Buy
+2,470
New +$276K 0.14% 142

Other funds holding LLY

FinTrust Capital Advisors's LLY Position: Q3 2024 in Review

FinTrust Capital Advisors increased its Eli Lilly (LLY) stake by 0.47% in Q3 2024, buying an estimated $8.09K and bringing the position to 1,918 shares worth $1.7M. The position accounts for 0.29% of the portfolio, ranked #82.

FinTrust Capital Advisors first reported a position in LLY in Q4 2018 and has held it in 24 quarters since. The position peaked at $1.73M in Q2 2024. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • FinTrust Capital Advisors held 1,918 shares of Eli Lilly worth $1.7M as of Q3 2024.
  • FinTrust Capital Advisors bought 9 Eli Lilly shares in Q3 2024, an estimated $8.09K.
  • Eli Lilly made up 0.29% of FinTrust Capital Advisors's portfolio in Q3 2024, its #82 holding.
  • FinTrust Capital Advisors first reported a position in Eli Lilly in Q4 2018 and has held it in 24 quarters since.
  • FinTrust Capital Advisors's Eli Lilly position peaked at $1.73M in Q2 2024.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.